ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures
ResMed Inc. (NYSE:RMD) is well positioned to benefit from the long-term growth of the global obstructive sleep apnea (OSA) treatment market.
Posts Tagged ‘NYSE:RMD’
ResMed’s (RMD) Sleep Business Booms Even As One Product Stumbles
On August 6, ResMed (NYSE:RMD) reported fourth-quarter fiscal 2026 results capping a year of double-digit growth.
Is ResMed Inc. (RMD) Stock Still a Long-Term Winner as OSA Market Expansion Continues?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. ResMed Inc. (NYSE:RMD) is among the best healthcare stocks.
10 Best Healthcare Stocks to Buy According to Wall Street Analysts
In this article, we will be taking a look at the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. The U.S.
Is ResMed Inc. (RMD) A Good Stock To Buy Now?
Is RMD a good stock to buy? We came across a bullish thesis on ResMed Inc. on r/investing_discussion by Variant_Invest.
10 Most Undervalued Large Cap Stocks to Buy According to Analysts
In this article, we will discuss the 10 Most Undervalued Large Cap Stocks to Buy According to Analysts.
ResMed Inc. (NYSE:RMD) Q3 2026 Earnings Call Transcript
ResMed Inc. (NYSE:RMD) Q3 2026 Earnings Call Transcript April 30, 2026 Operator: Welcome to the Q3 Fiscal Year 2026 ResMed Inc. Earnings Conference Call.
8 Best Long-Term ASX Stocks to Buy Right Now
In this piece, we shed light on the 8 Best Long-Term ASX Stocks to Buy Right Now.
ResMed Inc. (RMD) Gains Analyst Confidence as Price Targets Rise on Strong Earnings
ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc.
10 Best Medical Technology Stocks to Invest In
In this article, we will discuss the 10 Best Medical Technology Stocks to Invest In.
ResMed Inc. (RMD): A Bull Case Theory
We came across a bullish thesis on ResMed Inc. on Best Anchor Stocks’s Substack. In this article, we will summarize the bulls’ thesis on RMD.
ResMed Inc. (NYSE:RMD) Q2 2026 Earnings Call Transcript
ResMed Inc. (NYSE:RMD) Q2 2026 Earnings Call Transcript January 29, 2026ResMed Inc. beats earnings expectations. Reported EPS is $2.81, expectations were $2.74.
ResMed Inc. (NYSE:RMD) Q1 2026 Earnings Call Transcript
ResMed Inc. (NYSE:RMD) Q1 2026 Earnings Call Transcript October 30, 2025ResMed Inc. beats earnings expectations. Reported EPS is $2.55, expectations were $2.51.
ResMed Inc. (RMD): A Bull Case Theory
We came across a bullish thesis on ResMed Inc. on CompoundingLab’s Substack. In this article, we will summarize the bulls’ thesis on RMD.
ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress
In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. ResMed Inc. is placed fourth among them. ResMed Inc.
7 Hot Healthcare Stocks to Buy Right Now
In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. Dr.
ResMed Inc. (NYSE:RMD) Q4 2025 Earnings Call Transcript
ResMed Inc. (NYSE:RMD) Q4 2025 Earnings Call Transcript July 31, 2025ResMed Inc. beats earnings expectations. Reported EPS is $2.55, expectations were $2.49.
Jim Cramer Says The Day “Everything’s A Lot More Expensive” Is Coming & Discusses These 10 Stocks
In this piece, we will look at the stocks Jim Cramer recently discussed.
ResMed Inc. (NYSE:RMD) Q3 2025 Earnings Call Transcript
ResMed Inc. (NYSE:RMD) Q3 2025 Earnings Call Transcript April 23, 2025ResMed Inc. misses on earnings expectations. Reported EPS is $2.37 EPS, expectations were $2.38.
ResMed Inc. (RMD): A Bull Case Theory
We came across a bullish thesis on ResMed Inc. (RMD) on Substack by LongTermValue Research. In this article, we will summarize the bulls’ thesis on RMD. ResMed Inc.
Jim Cramer is Discussing These 10 Stocks Ahead of Q1 Earnings Season
In this article, we will take a detailed look at Jim Cramer is Discussing These 10 Stocks Ahead of Q1 Earnings Season.
Jim Cramer Recently Talked About These 12 Companies
Jim Cramer, host of Mad Money, warned investors on Friday that until there is more clarity regarding the tariff situation, they should brace for continued volatility.
ResMed Inc. (NYSE:RMD) Q2 2025 Earnings Call Transcript
ResMed Inc. (NYSE:RMD) Q2 2025 Earnings Call Transcript January 30, 2025ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32.
ResMed (RMD) Rose 15% in Q3
Fidelity Investments, an investment management company, recently released its “Fidelity Growth Strategies Fund” third quarter 2024 investor letter.
ResMed Inc. (NYSE:RMD) Q1 2025 Earnings Call Transcript
ResMed Inc. (NYSE:RMD) Q1 2025 Earnings Call Transcript October 24, 2024ResMed Inc. beats earnings expectations. Reported EPS is $2.2, expectations were $2.04.
ResMed Inc. (NYSE:RMD) Q4 2024 Earnings Call Transcript
ResMed Inc. (NYSE:RMD) Q4 2024 Earnings Call Transcript August 1, 2024ResMed Inc. beats earnings expectations. Reported EPS is $2.08, expectations were $2.07.
ResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcript
ResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcript April 25, 2024 ResMed Inc. beats earnings expectations. Reported EPS is $2.13, expectations were $1.91. ResMed Inc.
20 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
ResMed Inc. (NYSE:RMD) Q2 2024 Earnings Call Transcript
ResMed Inc. (NYSE:RMD) Q2 2024 Earnings Call Transcript January 24, 2024 ResMed Inc.
ResMed Inc. (NYSE:RMD) Q1 2024 Earnings Call Transcript
ResMed Inc. (NYSE:RMD) Q1 2024 Earnings Call Transcript October 26, 2023 ResMed Inc. beats earnings expectations. Reported EPS is $1.64, expectations were $1.62.
Billionaire Ken Griffin’s 2023 Portfolio: Top 15 Stock Picks
In this piece, we will take a look at the top fifteen stocks in billionaire Ken Griffin's 2023 portfolio.
ResMed Inc. (NYSE:RMD) Q3 2023 Earnings Call Transcript
ResMed Inc. (NYSE:RMD) Q3 2023 Earnings Call Transcript April 27, 2023 ResMed Inc. beats earnings expectations. Reported EPS is $1.68, expectations were $1.59.
30 Biggest SaaS Companies in the World in 2023
In this piece, we will take a look at the 30 biggest SaaS companies in the world. For more companies, head on over to 10 Biggest SaaS Companies in the World.
ResMed Inc. (NYSE:RMD) Q2 2023 Earnings Call Transcript
ResMed Inc. (NYSE:RMD) Q2 2023 Earnings Call Transcript January 26, 2023 ResMed Inc. beats earnings expectations. Reported EPS is $1.66, expectations were $1.62.
Billionaire Chamath Palihapitiya’s Portfolio, Stock Picks and Investment Ideas
In this article we will take a look at the 10 best stock picks and investments of billionaire Chamath Palihapitiya.
Is ResMed (RMD) Stock a Buy For 2021?
Carillon Eagle Mid Cap Growth Fund recently released its Q3 2020 Investor Letter, a copy of which you can download here.
Hedge Funds Are Crazy About ResMed Inc. (RMD)
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.
Here’s What Hedge Funds Think About ResMed Inc. (RMD)
Is ResMed Inc. (NYSE:RMD) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research.
Insider Buying Volume Hitting Historic Lows Should Not Worry Investors; Noteworthy Insider Transactions at 5 Companies
A recent article published by Bloomberg says that the number of corporate insiders, namely officers and directors, purchasing shares of their companies decreased by 44% from a...
What Has Propelled Insiders to Cash Out of These Strong-Performing Stocks?
All major U.S. indexes declined sharply on Friday, delivering the worst trading week since the major sell-off in August.
Hedge Fund Resource Center
